Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Darden, Humana, And Rocket Lab Are Among Top 10 Large Cap Losers Last Week (Sep. 15- Sep. 19): Are The Others In Your Portfolio?

Author: Nabaparna Bhattacharya | September 21, 2025 07:31am

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

  1. FactSet Research Systems Inc. (NYSE:FDS) stock fell 20.24% this week after multiple firms cut their respective price targets on the stock. The stock may be moving on continued weakness after the company issued FY26 EPS guidance below estimates.
  2. Darden Restaurants, Inc. (NYSE:DRI) stock slumped 13.35% this week after the company reported worse-than-expected Q1 financial results on Thursday. Multiple firms lowered their respective price targets on the stock.
  3. Builders FirstSource, Inc. (NYSE:BLDR) stock fell 11.66% this week. Wedbush analyst Jay McCanless downgraded the Stock from Outperform to Neutral and maintained the price forecast.
  4. DexCom, Inc. (NASDAQ:DXCM) stock fell 11.76% this week after Hunterbrook Capital on Thursday issued a short report.
  5. Sprouts Farmers Market Inc (NASDAQ:SFM) stock fell 11.14% this week.
  6. Maplebear Inc. (NASDAQ:CART) stock fell 12.64% this week. BTIG analyst Jake Fuller maintains a Buy rating and lowered the price forecast from $58 to $55.
  7. Rocket Lab Corporation (NASDAQ:RKLB) fell 10.71% this week after the company disclosed it may offer and sell up to $750 million of common stock from time to time.
  8. Humana Inc. (NYSE:HUM) stock fell 7.41% this week.
  9. Amrize Ltd (NYSE:AMRZ) stock fell 8.35% this week.
  10. Carlisle Companies Incorporated (NYSE:CSL) stock fell 7.54% this week. JP Morgan analyst Tomohiko Sano maintains an Overweight rating, lowering the price forecast from $480 to $410.

Read Next:

Posted In: AMRZ BLDR CART CSL DRI DXCM FDS HUM RKLB SFM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist